Overview. Petronas Chemicals (PChem) 4Q22 headline profits plunged 75% QoQ and 77% YoY to RM0.5bn due to (i) weaker profit from olefin and derivative (O&D) segment, (ii) non-core forex loss of RM412mn, and (iii) one-off earn-out payment of RM204mn related to new subsidiary Perstorp’s new plant in Sayakha, India. Excluding these non-core items, PChem core profits came at RM1.1bn.
FY22 performance. FY22 core profit declined slightly by 5% to RM6.9bn due to weak 4Q22 result. PChem also recorded weaker plant utilisation (PU) of 89% in FY22 from 93% in FY21. Nonetheless, sales volume rose 1% YoY to 8.3mn MT mainly due to additional volume from Perstorp which was acquired in 4Q22.
Against estimates: Below. FY22 earnings are below both our and consensus’ estimate at 87% and 92% respectively. The deviation against our forecast was due to actual opex that came in above expectation. Hence, we trim our FY23F/FY24F/FY25F earnings forecast by 10%/11%/14% (Table 4) to account for higher opex.
Dividend. A final DPS of 16sen was declared which is lower than 4Q21 DPS of 23sen. This brings YTD DPS of 41sen (FY21: 56sen) which implies payout ratio of 48% (FY21: 62%).
Pengerang Integrated Complex (PIC). PChem expects to reach the commercial operation date (COD) for PIC in 2H23.
Outlook. Management guided that demand for O&D has recovered slightly following China’s economic re-opening. However, urea prices are weaker given current off planting season.
Our call. We maintain PChem as a HOLD with a lower TP of RM8.30 (from RM8.90) following our earnings revision. Despite our earnings revision, we think there’s still some downside risk to our forecast due to softer urea prices.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....